Impact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience

February 18, 2025 updated by: Albany Medical College

Randomized Control Trial: Impact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience.

The purpose of this study is to assess whether patient-selected visual art for patients admitted to the antepartum unit will increase hospital satisfaction compared to routine care.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Kathryne Kostamo, MD
  • Phone Number: 727-742-2450
  • Email: kostamk@amc.edu

Study Locations

  • United States
    • New York
      • Albany, New York, United States, 12208
        • Recruiting
        • Albany Medical Center
        • Contact:
        • Contact:
        • Contact:
          • Kathryne Kostamo, MD
        • Contact:
          • Rachel Fried, MD
        • Contact:
          • Molly Dexter
        • Contact:
          • Monali Ardeshna
        • Contact:
          • Kimberly Lipton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients who are greater than or equal to 18 years of age
  • patients admitted to the study hospital's antepartum unit for care
  • currently pregnant
  • willing and able to provide informed consent and complete the provided questionnaire

Exclusion Criteria:

  • patients less than 18 years of age
  • patients who are not pregnant
  • patients who are not admitted to study hospital's antepartum unit
  • patients who cannot provide informed consent in English
  • patients who have participated in this study during a previous admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Visual art Intervention
Patient-selected visual art Routine care
Other: Patient-selected visual art in hospital room
Patient-selected visual art placed in patient's antepartum hospital room
Other Names:
  • Patient-selected visual art
  • Visual art
Active Comparator: Control
Routine care
Other: Routine care
Patient will receive routine care, and will not select, nor have, visual art in their antepartum hospital room.
Other Names:
  • Control
  • No visual art

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HCAHPS Survey Overall Hospital Rating
Time Frame: through study completion, an average of 2 years
Overall hospital rating question #18 from HCAPHS Survey
through study completion, an average of 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Qualitative Experience
Time Frame: through study completion, an average of 2 years
Likert Scale Questions and Open-ended Questions regarding patient's experience with visual art and hospital stay
through study completion, an average of 2 years
Portion of HCAHPS Survey regarding Patient Experience
Time Frame: through study completion, an average of 2 years
Likert and Rating of patient's experience of hospitalization
through study completion, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Albany Medical College

Investigators

  • Principal Investigator: Scott Dexter, MD, Albany Medical College

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 11, 2024

First Submitted That Met QC Criteria

January 22, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 18, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 6960 (NORC)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Complications

Clinical Trials on Patient-selected visual art in hospital room

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe